NeuroPace annual depreciation and amortization
2020
2021
2022
2023
2024
2025
NeuroPace Depreciation & Amortization Growth & History (NPCE)
NeuroPace's depreciation and amortization was $238,000 for fiscal 2025.
View full NeuroPace company overviewNeuroPace annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $238,000 | $31,000 | +14.98% |
| 2024 | 2024-12-31 | $207,000 | $35,000 | +20.35% |
| 2023 | 2023-12-31 | $172,000 | −$95,000 | −35.58% |
| 2022 | 2022-12-31 | $267,000 | −$29,000 | −9.80% |
| 2021 | 2021-12-31 | $296,000 | −$16,000 | −5.13% |
| 2020 | 2020-12-31 | $312,000 | — | — |
NeuroPace quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $100,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $60,000 | $11,000 | +22.45% |
| Q4 2025 | 2025-12-31 | $522,000 | — | — |
| Q3 2025 | 2025-09-30 | $100,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $100,000 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $49,000 | $4,000 | +8.89% |
| Q3 2024 | 2024-09-30 | $100,000 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $100,000 | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $45,000 | −$3,000 | −6.25% |
| Q3 2023 | 2023-09-30 | $100,000 | $0 | 0.00% |
| Q2 2023 | 2023-06-30 | $100,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $48,000 | −$32,000 | −40.00% |
| Q3 2022 | 2022-09-30 | $100,000 | $0 | 0.00% |
| Q2 2022 | 2022-06-30 | $100,000 | $0 | 0.00% |
| Q1 2022 | 2022-03-31 | $80,000 | $6,000 | +8.11% |
| Q3 2021 | 2021-09-30 | $100,000 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $100,000 | $0 | 0.00% |
| Q1 2021 | 2021-03-31 | $74,000 | −$8,000 | −9.76% |
| Q3 2020 | 2020-09-30 | $100,000 | — | — |
| Q2 2020 | 2020-06-30 | $100,000 | — | — |
| Q1 2020 | 2020-03-31 | $82,000 | — | — |
NeuroPace depreciation and amortization trends
Over the last five fiscal years, NeuroPace's depreciation and amortization decreased from $312,000 to $238,000, a change of −$74,000. The latest reported quarter, Q2 2026, shows $100,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NeuroPace source filings ↗